Human biology is like a puzzle with countless pieces, but Artificial Intelligence (AI) and machine learning are helping us fit them together better. The goal? Creating better medicines more quickly to treat and even cure more people.
Right now, many diseases don’t have a cure because finding new drugs is really hard and takes a long time and lots of money. But there’s a bright side: experts believe that AI, when used the right way in scientific research, could change all that. It might make drug discovery much faster and accessible to more people who need treatment.
In the world of biotech startups, AI is making big waves. A report called “The Landscape of Artificial Intelligence (AI) in Pharmaceutical R&D” shows that the number of AI-driven companies working on drug discovery has grown from just 62 in 2011 to a whopping 400 in 2022.
AI and the Future of Drug Discovery
Machine Learning (ML), a type of AI, is like a super-smart assistant for drug discovery. It can simulate how molecules behave and predict which ones might make good medicines. This helps scientists design drugs more efficiently. For example, a special AI system called AlphaFold is so good at predicting the shapes of proteins that it rivals experiments.
But there’s a catch. ML isn’t perfect. It needs lots of high-quality data, and sometimes it’s like a black box – it’s hard to understand why it makes certain predictions. This means we need new approaches to make it work even better.
Innovations on the Horizon
In the world of AI-driven startups, exciting things are happening in three areas:
Finding Targets: ML is helping identify potential targets for new medicines by studying diseases. Think of it as finding clues to solving a puzzle. It’s like having a map to find hidden treasure.
Smart Drug Design: Some startups are teaching their AI systems to be more flexible, so they can design different medicines. It’s like having a robot chemist that can create custom-made molecules.
Picking the Best: AI can sift through a massive library of molecules and figure out which ones are most likely to work as medicines. It’s like having a super-fast librarian who finds the best books for you.
Beyond Discovery: Drug Delivery Revolution
But AI’s impact doesn’t stop at drug discovery. Researchers are creating data models of individual patients, often referred to as “digital twins.” These digital twins could allow scientists to run virtual trials before conducting expensive real-world ones. This approach reduces the time and investment required to create a drug, making life-enhancing interventions more commercially viable and allowing treatments to be targeted precisely to those who will benefit most.
AI and ML are changing the game in drug discovery, personalized medicine, and now even drug delivery. They’re like a powerful magnifying glass helping scientists see things they couldn’t before. The future of medicine is looking brighter, with the promise of faster drug discovery, more tailored treatments, and efficient drug delivery methods that can change lives.
Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ. Machine Learning in Drug Discovery: A Review. Artif Intell Rev. 2022;55(3):1947-1999. doi: 10.1007/s10462-021-10058-4. Epub 2021 Aug 11. PMID: 34393317; PMCID: PMC8356896.
Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, Li B, Madabhushi A, Shah P, Spitzer M, Zhao S. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019 Jun;18(6):463-477. doi: 10.1038/s41573-019-0024-5. PMID: 30976107; PMCID: PMC6552674.
Dara S, Dhamercherla S, Jadav SS, Babu CM, Ahsan MJ. Machine Learning in Drug Discovery: A Review. Artif Intell Rev. 2022;55(3):1947-1999. doi: 10.1007/s10462-021-10058-4. Epub 2021 Aug 11. PMID: 34393317; PMCID: PMC8356896.
Nayarisseri A, Khandelwal R, Tanwar P, Madhavi M, Sharma D, Thakur G, Speck-Planche A, Singh SK. Artificial Intelligence, Big Data and Machine Learning Approaches in Precision Medicine & Drug Discovery. Curr Drug Targets. 2021;22(6):631-655. doi: 10.2174/1389450122999210104205732. PMID: 33397265.
Tran KA, Kondrashova O, Bradley A, Williams ED, Pearson JV, Waddell N. Deep learning in cancer diagnosis, prognosis and treatment selection. Genome Med. 2021 Sep 27;13(1):152. doi: 10.1186/s13073-021-00968-x. PMID: 34579788; PMCID: PMC8477474.
